Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Kikkoman Biochemifa is a specialized subsidiary of the Kikkoman Corporation, leveraging the parent company's extensive history in fermentation technology to produce high-quality biochemicals. The company is globally recognized for its LuciPac and Lumitester hygiene monitoring systems, which utilize patented bioluminescence technology to detect ATP, ADP, and AMP for rapid cleanliness verification. Beyond diagnostics, Kikkoman Biochemifa manufactures a diverse portfolio of enzymes for clinical chemistry, food processing, and molecular biology research. They also produce pharmaceutical and cosmetic grade hyaluronic acid through advanced fermentation processes. Headquartered in Tokyo, the company serves the global healthcare, food safety, and life science industries as a critical supplier of reagents and analytical tools.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Kikkoman Biochemifa.